Zhang Xin

Prof. Zhang Xin

Shanghai Serum Biotechnology Co.,LTD,Qingpu, Shanghai, China
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Brain Research Bulletin
Verified
Journal Article
Closed access
HWHong-Tao Wang
Hong-Tao Wang
LZLin Zeng
Lin Zeng
Zhang XinZhang Xin
Zhang Xin
KLKui Li
Kui Li
YZYong Zu
Yong Zu
ZHZe-Lan Hu
Ze-Lan Hu

15 June 2013 in Indian Journal of Pathology and Microbiology
Verified
Journal Article
Closed access
PDF file
ZHZe-Lan Hu
Ze-Lan Hu
Zhang XinZhang Xin
Zhang Xin
MSMing Shi
Ming Shi
ZTZhi-Wen Tian
Zhi-Wen Tian
YHYing Huang
Ying Huang
YDYuqiang Ding
Yuqiang Ding
Somatosensory ganglia including dorsal root ganglion (DRG) and trigeminal ganglion (TG) are derived from a common pool of neural crest stem cells (NCCs), and are good systems to study the mechanisms of neurogenesis and gliogenesis. Previous studies have reported that deletion of Rbpj, a critical integrator of activation signals from all Notch receptors, in NCCs and their derived cells resulted in the delayed gliogenesis at early stage and a loss of glial cells at later stage in the DRG. But the phenotypes in the TG have not been described. Here we reported although the gliogenesis was also delayed initially in Rbpj-deficient TG, it was recovered as the development progressed, as shown by the presence of large number of glial cells in the TG at later stages. However, neuronal reduction was observed in Rbpj-deficient TG, which is similar to what observed in Rbpj-deficient DRG. Taken together, our data indicate the function of Rbpj is diversified and context dependent in the gliogenesis of somatosensory ganglia.

1 January 2015 in Neuroscience
Verified
Journal Article
Closed access
HWH.-T. Wang
H.-T. Wang
LZL. Zeng
L. Zeng
QCQ. Chen
Q. Chen
Zhang XinZhang Xin
Zhang Xin
JLJ.-W. Liu
J.-W. Liu
ZHZ.-L. Hu
Z.-L. Hu

31 January 2022 in Toxicon
Verified
Journal Article
Closed access
MZMin Zhang
Min Zhang
SYShuo Yu
Shuo Yu
Zhang XinZhang Xin
Zhang Xin
QHQiuyuan Huang
Qiuyuan Huang
YHYue Huang
Yue Huang
QDQiuyun Dai
Qiuyun Dai

1 April 2022 in Toxins
Verified
Journal Article
Open access
PDF file
BWBo Wang
Bo Wang
GLGuoyan Liu
Guoyan Liu
MLMin Luo
Min Luo
Zhang XinZhang Xin
Zhang Xin
QWQianqian Wang
Qianqian Wang
LZLiming Zhang
Liming Zhang
Sea snake venom is extremely toxic, and it can induce severe respiratory failure and cause high mortality. The most effective first aid treatment for sea snake bites is to inject antivenom as soon as possible. However, in China, there are only four types of terrestrial snake antivenoms, none of which are effective in the treatment of sea snake bites. In order to develop an antivenom for the dominant species of sea snakes in Chinese seas, Hydrophis curtus venom (HcuV) was chosen as the antigen to immunize horses. From immune plasma, a high-titer Hydrophis curtus antivenom (HcuAV) was prepared. In vitro assessment showed that HcuAV had a cross-neutralizing capacity against HcuV and Hydrophis cyanocinctus venom (HcyV). In vivo assessment indicated that HcuAV injection could significantly improve the survival rates of the HcuV and HcyV envenomated mice (0% to 100% and 87.5%, respectively) when it was injected at a sufficient amount within the shortest possible time. In addition, HcuAV could also effectively alleviate multiple organ injuries caused by HcuV. These results provide experimental support for the future clinical application of HcuAV.